These findings suggest that once the specific mechanisms of CEP120 and SPDL1 in IDD are elucidated, these drugs and molecular compounds could offer new therapeutic avenues for the treatment of IDD. The gene discussed is SPDL1; the disease is intervertebral disk degenerative disorder.